1.0Feb 11, 2026Sales territory managerCurrent employee, more than 1 yearDallas-Fort WorthRecommendCEO approvalBusiness outlookProsGood technology for renal denervationConsToxic leadership, Don't know what they're doing.Show more
5.0Oct 1, 2024Preclinical scientistCurrent employeePalo Alto, CARecommendCEO approvalBusiness outlookProsgood team and manager, hybrid work environmentConsthere is no stock optionsShow moreHelpfulShare2
2.0Jun 3, 2026Sales representativeCurrent employeeRecommendCEO approvalBusiness outlookProsthe device is a game changerConsThey do not pay, poor leadership, unrealistic quotasShow moreHelpfulShare